4.5 Article

Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders

Related references

Note: Only part of the references are listed.
Article Allergy

Increased group 2 innate lymphoid cells in peripheral blood of adults with mastocytosis

Esmee K. van der Ploeg et al.

Summary: ILC2 levels were significantly higher in patients with systemic mastocytosis carrying the D816V mutation compared with non-carriers or healthy controls. Skin involvement and itch in patients were associated with higher levels of ILC2s, independent of atopy or serum tryptase levels. Majority of ILC2s did not carry the D816V mutation, suggesting a role for ILC2s in mastocytosis pathogenesis through crosstalk with mast cells.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Letter Allergy

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

Matthew P. Giannetti et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Review Allergy

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

Theo Gulen et al.

Summary: Research on mast cell activation and syndromes has advanced in recent years, but there is ongoing debate about diagnostic and classification criteria, highlighting the importance of applying consensus criteria to ensure accurate diagnosis and treatment.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Article Multidisciplinary Sciences

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jerome Hadjadj et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Article Immunology

T cell responses in patients with COVID-19

Zeyu Chen et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement

Nikaia Smith et al.

NATURE COMMUNICATIONS (2017)

Review Immunology

Mast cells as regulators of T cell responses

Silvia Bulfone-Paus et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Virology

Mast Cell-Induced Lung Injury in Mice Infected with H5N1 Influenza Virus

Yanxin Hu et al.

JOURNAL OF VIROLOGY (2012)

Article Immunology

Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells

Alessandra Mazzoni et al.

JOURNAL OF IMMUNOLOGY (2006)